Affiliation:
1. Department of Biomedical Sciences, University of Cagliari, 09042 Cagliari, Italy
2. School of Neuroscience, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA
Abstract
Cannabis is the most used drug of abuse worldwide. It is well established that the most abundant phytocannabinoids in this plant are Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). These two compounds have remarkably similar chemical structures yet vastly different effects in the brain. By binding to the same receptors, THC is psychoactive, while CBD has anxiolytic and antipsychotic properties. Lately, a variety of hemp-based products, including CBD and THC, have become widely available in the food and health industry, and medical and recreational use of cannabis has been legalized in many states/countries. As a result, people, including youths, are consuming CBD because it is considered “safe”. An extensive literature exists evaluating the harmful effects of THC in both adults and adolescents, but little is known about the long-term effects of CBD exposure, especially in adolescence. The aim of this review is to collect preclinical and clinical evidence about the effects of cannabidiol.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference288 articles.
1. History of cannabis and the endocannabinoid system;Crocq;Dialogues Clin. Neurosci.,2020
2. The Cannabis Spread throughout the Continents and its Therapeutic Use in History;Charitos;Endocr. Metab. Immune Disord. Drug Targets,2021
3. History of cannabis as a medicine: A review;Zuardi;Braz. J. Psychiatry,2006
4. The religious and medicinal uses of Cannabis in China, India and Tibet;Touw;J. Psychoact. Drugs,1981
5. NIDA (2000). Archive Materials for the National Institute on Drug Abuse.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献